Noncytolytic control of viral infections by the innate and adaptive immune response

Annual Review of Immunology

Volumn 19, Issue , 2001, Pages 65-91

  Guidotti, L G ^a   Chisari, F V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adaptive immunity; Cytokines; Innate immunity; Noncytolytic antiviral mechanisms; Viruses

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; EPITOPE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; GRANULOCYTE; HELPER CELL; HUMAN; HUMORAL IMMUNITY; INFECTION CONTROL; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CYTOKINES; DENDRITIC CELLS; GRANULOCYTES; HUMANS; IMMUNITY, NATURAL; INTERFERONS; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 0035062597     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.19.1.65     Document Type: Review

References (191)

1. Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication
2. Perspective: Virus infections and the death of neurons
3. Role of virus-induced apoptosis in a host defense mechanism against virus infection
4. Interferons and other cytokines
5. HIV-1, macrophages, glial cells, and cytokinesin AIDS nervous system disease
6. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver
7. Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha;-treated hepatocytes
8. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection
9. Role of interferon in resistance to viral infection in vivo
10. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and gamma interferon
11. Functional role of type I and type II interferons in antiviral defense
12. Biological functions of IFN-gamma and IFN-alpha/beta: Lessons from studies in gene knockout mice
13. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo
14. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines
15. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon
16. High level hepatitis B virus replication in transgenic mice
17. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
18. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
19. Reoviruses and the interferon system
20. Stimulation of naive and memory T cells by cytokines
21. Novel trends in neutrophil structure, function and development
22. The biology of chemokines and their receptors
23. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea
24. The interaction of neutrophils with respiratory epithelial cells in viral infection
25. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity
26. Eosinophils, ribonucleases and host defense: Solving the puzzle
27. The role of eosinophils and neutrophils in inflammation
28. Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies
29. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation
30. Chemokines and the allergic response
31. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line
32. Expression of eotaxin by normal airway epithelial cells after influenza virus A infection
33. The role of mast cells in inflammatory reactions of the airways, skin and intestine
34. Eosinophils bind rhinovirus and activate virus-specific T cells
35. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
36. NK cell receptors
37. Viral subversion of the immune system
38. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice
39. Requirement for natural killer cell-produced interferon g in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
40. Characterization of early IL-12, IFN-α/β, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection
41. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients
42. Severe herpesvirus infections in an adolescent without natural killer cells
43. Susceptibility of adenovirus 2-transformed rat cell lines to natural killer (NK) cells: Direct correlation between NK resistance and in vivo tumorigenesis
44. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection
45. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo
46. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype
47. Murine natural killer cells limit coxsackievirus B3 replication
48. Mouse CD1-specific NK1 T cells: Development, specificity, and function
49. Mouse CD1 is mainly expressed on hemopoietic-derived cells
50. + NK T lymphocytes
51. CD1-restricted T cell recognition of microbial lipoglycan antigens
52. Murine natural killer T(NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls
53. + effector function against intracellular infection
54. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
55. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors
56. Natural killer T cell activation inhibits HBV replication in vivo
57. Macrophages and inflammatory mediators in tissue injury
58. Of microbes and macrophages: Entry, survival and persistence
59. Inhibition of herpes simplex virus multiplication by activated macrophages: A role of arginase
60. In vitro antiviral properties of endotoxin activated rat Kupffer cells
61. Macrophage activation for cytolysis of vitally infected target cells
62. Interaction of mouse hepatitis virus 3 with Kupffer cells explanted from susceptible and resistant mouse strains. Antiviral activity, interleukin-1 synthesis
63. Interleukin-18
64. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice
65. Interleukin-12 inhibits hepatitis B virus replication in HBV transgenic mice
66. Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections
67. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon
68. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection
69. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection
70. Does nitric oxide play a critical role in viral infections?
71. An antiviral mechanism of nitric oxide: Inhibition of a viral protease
72. Nitric oxide inhibits hepatitis B virus replication in the liver of transgenic mice
73. + T cells
74. A chemokine trap for HIV co-receptors
75. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS
76. Dendritic cells and the control of immunity
77. Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies
78. The distinctive features of influenza virus infection of dendritic cells
79. Dendritic cells: Immunological sentinels with a central role in health and disease
80. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
81. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis virus within a syngeneic or semiallogeneic system
82. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific
83. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
84. Immune function in mice lacking the perforin gene
85. Theiler's virus infection of perforin-deficient mice
86. + T cells clear influenza virus by perforin or Fas-dependent processes
87. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection
88. + T cell effector mechanisms in resistance to infection
89. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
90. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
91. Cytokine-induced viral purging-role in viral pathogenesis
92. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice
93. Interleukin 2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways
94. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-g
95. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection
96. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo
97. Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo
98. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands
99. Participation of endogenous tumour necrosis factor {a} in host resistance to cytomegalovirus infection
100. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: Interferon gamma, but not tumour necrosis factor α, displays antiviral activity in vivo
101. An essential role for type 1 interferon-gamma in terminating persistent viral infection
102. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice
103. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in HBV envelope transgenic mice
104. Differential target cell sensitivity to cytotoxic T lymphocyte-activated death pathways in vivo
105. Viral clearance without destruction of infected cells during acute HBV infection
106. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes
107. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte
108. Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha
109. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver
110. Mechanisms of viral clearance in perforin-deficient mice
111. IFN-gamma is required for viral clearance from central nervous system oligodendroglia
112. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon
113. Coxsackievirus B3-induced myocarditis: Perforin exacerbates disease, but plays no detectable role in virus clearance
114. + T cells
115. +) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration
116. Th-1 and Th-2 cells: Different patterns of lymphokine secretion lead to different functional properties
117. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection
118. + T cells during acute infection with lymphocytic choriomeningitis virus
119. +) T cells and Th1 dominance during lymphocytic choriomeningitis virus infection
120. + T cell frequencies from acute infection into long term memory
121. + T cells
122. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells
123. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
124. +) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability
125. + T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses
126. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses
127. Pathogenetic effector function of CD4-positive T-helper-1 cells in hepatitis B virus transgenic mice
128. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins
129. Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody
130. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain
131. + T-cell mechanisms in the control of respiratory virus infections
132. +) T cells in controlling retrovirus replication and spread in persistently infected mice
133. The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease
134. The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: Lessons from the friend virus model
135. Complement, viruses, and virus-infected cells
136. The role of antibody and complement in the control of viral infections
137. Antibody and virus: Binding and neutralization
138. Antibody-mediated clearance of alphavirus infection from neurons
139. Control of Sindbis virus infection by antibody in interferon-deficient mice
140. Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated down-regulation of Sindbis virus replication in persistently infected neurons
141. Neutralizing antiviral B cell responses
142. Immunity to viruses in B cell-deficient mice: Influence of antibodies on virus persistence and on T cell memory
143. Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice
144. +) T cells in the Friend murine retrovirus neutralizing antibody response: Evidence for functional T cells in genetic low-recovery mice
145. Hepatitis B virus immunopathogenesis
146. The role of immune responses in the pathogenesis of hepatitis C virus infection
147. Hepatitis B virus persistence after recovery from acute viral hepatitis
148. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T lymphocyte response
149. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
150. Viral persistence in vivo through selection of neutralizing antibody-escape variants
151. Control of early viral and bacterial distribution and disease by natural antibodies
152. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities
153. How cells respond to interferons
154. An overview of the interferon system: Signal transduction and mechanisms of action
155. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs
156. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
157. Fascination with 2-5 A-dependent RNase: A unique enzyme that functions in interferon action
158. The antiviral enzymes PKR and RNase L suppress gene expression from viral and nonviral based vectors
159. Alternative function of a protein kinase homology domain in 2′,5′-oligoadenylate dependent RNase L
160. Regulation of human immunodeficiency virus replication by 2′,5′-oligoadenylate-dependent RNase L
161. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection
162. Inducible expression of the 2-5 A synthetase/RNase L system results in inhibition of vaccinia virus replication
163. Mx proteins: Mediators of innate resistance to RNA viruses
164. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids
165. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
166. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
167. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: A potential mechanism of interferon resistance
168. Mechanism of interferon action: Double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons
169. Intrahepatic induction of IFN-α/β eliminates viral RNA-containing capsids in HBV transgenic mice
170. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways
171. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis
172. Post-transcriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes
173. La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA
174. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice
175. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs
176. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells
177. Cytokine responses in virus infections: Effects on pathogenesis, recovery and persistence
178. Virus interception of cytokine-regulated pathways
179. Subversion of cytokine networks by viruses
180. Immune evasion by adenoviruses
181. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
182. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
183. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments
184. A cytomegalovirus glycoprotein reroutes MHC class I complexes to lysosomes for degradation
185. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes, with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules
186. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis
187. Herpes simplex virus inhibitor ICP47 destabilizes the transporter associated with antigen processing (TAP) heterodimer
188. The active site of ICP47, a herpes simplex virus - Encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues
189. Transcription of interferon stimulated genes is induced by adenovirus particles but is suppressed by E1A products
190. Virus-encoded receptors for cytokines and chemokines